FDA & Life Sciences

• FDA Details Authorized Treatment Pathways and Collection Requirements for Administration of COVID-19 Convalescent Plasma (April 21, 2020)
• Seeking Solutions for Scarce Resources: Options to Boost Medical Supplies and Devices to Battle COVID-19 (March 26, 2020)
• FDA Issues Guidance on COVID-19 Disruptions to Clinical Trials (March 19, 2020)
• Novel Coronavirus 2019-nCoV and FDA’s Emergency Use Authorization Authority (February 26, 2020)